Home » Topics » New compound, BioWorld Science

New compound, BioWorld Science
RSS

Eisai prepares potent antitumor agents

April 11, 1997

TX-1877: new hypoxic cell radiation enhancer

April 11, 1997

Fujisawa describes new oral cephem antibiotic

April 11, 1997

Fujsawa selects adenosine A1 receptor antagonist for development

April 11, 1997

MDR-reversing agents described by Nikken Chemicals

April 11, 1997

New LTD4 antagonist from Fujisawa

April 10, 1997

New carbamate derivative from Kyorin with high affinity/selectivity for M1 receptors

April 10, 1997

Senju describes new calpain inhibitor

April 10, 1997

FR-138104: a new D2 antagonist from Fujisawa

April 10, 1997

New bradykinin B2 antagonist from Fujisawa

April 10, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...